Characterization of FDG PET Images Using Texture Analysis in Tumors of the Gastro-Intestinal Tract: A Review
暂无分享,去创建一个
Anne-Leen Deleu | Machaba Junior Sathekge | Alex Maes | Bart De Spiegeleer | Mike Sathekge | Christophe Van de Wiele | A. Maes | C. Van de Wiele | B. De Spiegeleer | M. Sathekge | Anne-Leen Deleu | Machaba Junior Sathekge | B. de Spiegeleer
[1] Frank J. Brooks,et al. Tracer Uptake The Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of , 2013 .
[2] M. Hatt,et al. Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer , 2011, The Journal of Nuclear Medicine.
[3] T. Yoshiura,et al. A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[4] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[5] Richard L. Wahl,et al. FDG-PET Determination of Metabolically Active Tumor Volume and Comparison with CT. , 1998, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[6] Arturo Brunetti,et al. Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging , 2019, World journal of gastroenterology.
[7] Peter Smeets,et al. Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[8] S. G. Jennings,et al. Positron-emission tomography and computed tomography of cystic pancreatic masses. , 2007, Clinical radiology.
[9] A. Rahmim,et al. Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features. , 2019, European journal of radiology.
[10] Robert J. Gillies,et al. The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis , 2015, Scientific Reports.
[11] Vicky Goh,et al. The effects of segmentation algorithms on the measurement of 18F-FDG PET texture parameters in non-small cell lung cancer , 2017, EJNMMI Research.
[12] S M Larson,et al. Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding , 1997, Cancer.
[13] D. Klimstra,et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.
[14] John O. Prior,et al. Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinoma , 2017, Oncotarget.
[15] Laurence E Court,et al. The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer , 2016, The Journal of Nuclear Medicine.
[16] Hao Zhang,et al. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. , 2012, Academic radiology.
[17] Dimitris Visvikis,et al. Characterization of PET/CT images using texture analysis: the past, the present… any future? , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[18] Christopher Marshall,et al. Development and validation of a prognostic model incorporating texture analysis derived from standardised segmentation of PET in patients with oesophageal cancer , 2017, European Radiology.
[19] Jianhua Ma,et al. Radiomic signature of 18F fluorodeoxyglucose PET/CT for prediction of gastric cancer survival and chemotherapeutic benefits , 2018, Theranostics.
[20] H. Matsubara,et al. Imaging biomarkers for the treatment of esophageal cancer , 2019, World journal of gastroenterology.
[21] Stephen S F Yip,et al. Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction , 2016, Physics in medicine and biology.
[22] Irène Buvat,et al. Understanding Changes in Tumor Texture Indices in PET: A Comparison Between Visual Assessment and Index Values in Simulated and Patient Data , 2017, The Journal of Nuclear Medicine.
[23] S. Parsons,et al. MAGIC in practice: Experience of peri‐operative ECF/X chemotherapy in gastro‐esophageal adenocarcinomas , 2012, Journal of surgical oncology.
[24] H. Sakahara,et al. Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas , 2000, Cancer.
[25] N. Aide,et al. Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs) , 2017, EJNMMI Research.
[26] M. Hatt,et al. (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. , 2016, The British journal of radiology.
[27] R. Jeraj,et al. Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters , 2010, Acta oncologica.
[28] O. Schillaci,et al. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT , 2007, La radiologia medica.
[29] In-Hwan Kim. Current status of adjuvant chemotherapy for gastric cancer , 2019, World journal of gastrointestinal oncology.
[30] E. Medico,et al. Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[31] T. Beyer,et al. Impact of intensity discretization on textural indices of [18F]FDG-PET tumour heterogeneity in lung cancer patients , 2019, Physics in medicine and biology.
[32] Robin P Boushey,et al. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. , 2009, Clinics in colon and rectal surgery.
[33] T. Yoshiura,et al. Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[34] J. E. van Timmeren,et al. Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score. , 2018, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[35] E W Steyerberg,et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. , 2012, The New England journal of medicine.
[36] T. Naruke,et al. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. , 2005, The Annals of thoracic surgery.
[37] Shan Tan,et al. Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy. , 2013, International journal of radiation oncology, biology, physics.
[38] Hao Zhang,et al. Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer , 2013, International Journal of Computer Assisted Radiology and Surgery.
[39] S. Hyun,et al. Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma , 2016, European Journal of Nuclear Medicine and Molecular Imaging.
[40] D. Lee,et al. Differentiation of mediastinal FDG uptake observed in patients with non-thoracic tumours , 2004, European Journal of Nuclear Medicine and Molecular Imaging.
[41] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[42] Adelin Albert,et al. FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[43] M. Soussan,et al. A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET , 2018, The Journal of Nuclear Medicine.
[44] S. Kumano,et al. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions , 2009, Annals of nuclear medicine.
[45] Dong Soo Lee,et al. Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology , 2014, Nuclear Medicine and Molecular Imaging.
[46] D. Girling. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial , 2002, The Lancet.
[47] V. Goh,et al. Exploratory radiomic features from integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging are associated with contemporaneous metastases in oesophageal/gastroesophageal cancer , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[48] C. Van de Wiele,et al. FDG uptake, a surrogate of tumour hypoxia? , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[49] D. Townsend,et al. Impact of Image Reconstruction Settings on Texture Features in 18F-FDG PET , 2015, The Journal of Nuclear Medicine.
[50] D. Nieboer,et al. Accuracy of Detecting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis. , 2020, Annals of surgery.
[51] Vicky Goh,et al. Quantifying tumour heterogeneity in 18F-FDG PET/CT imaging by texture analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.
[52] Hong Soo Kim,et al. Emerging role of 18F-fluorodeoxyglucose positron emission tomography for guiding management of hepatocellular carcinoma , 2019, World journal of gastroenterology.
[53] P. Marsden,et al. False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review , 2015, PloS one.
[54] M. Soussan,et al. 18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer , 2015, PloS one.
[55] S. Saglam,et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[56] Su Ruan,et al. Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier , 2017, PloS one.
[57] M. Hatt,et al. 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort , 2015, The Journal of Nuclear Medicine.
[58] Richard Tuli,et al. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. , 2017, Journal of gastrointestinal oncology.
[59] B J Krause,et al. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go. , 2011, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[60] Barry A Siegel,et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.